A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2022.2074193
Abstract: Abstract Aims Renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is commonly used to reduce the risk of death and to slow down disease progression in patients with chronic kidney disease (CKD), heart failure (HF) and hypertension. However,… read more here.
Keywords: disease; cost; therapy; patiromer ... See more keywords
Patiromer for the treatment of hyperkalemia
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2020.1774363
Abstract: ABSTRACT Introduction Hyperkalemia is a chronic and life-threatening electrolyte disorder that affects millions of patients around the world with decreased kidney function, hypertension, and heart failure. Recently newer oral potassium-binding agents have been approved for… read more here.
Keywords: potassium; use; patiromer; hyperkalemia ... See more keywords
Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial
Sign Up to like & getrecommendations! Published in 2022 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehac401
Abstract: Abstract Aims To investigate the impact of patiromer on the serum potassium level and its ability to enable specified target doses of renin–angiotensin–aldosterone system inhibitor (RAASi) use in patients with heart failure and reduced ejection… read more here.
Keywords: heart failure; failure reduced; hyperkalemia; patiromer ... See more keywords
Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia
Sign Up to like & getrecommendations! Published in 2022 at "Drug, Healthcare and Patient Safety"
DOI: 10.2147/dhps.s338579
Abstract: Abstract Hyperkalemia remains one of the most difficult consequences of disease state and treatment for patients with chronic kidney disease, heart failure, and diabetes. Controlling hyperkalemia can be difficult, but has become easier with the… read more here.
Keywords: treatment hyperkalemia; hyperkalemia; patiromer; efficacy safety ... See more keywords